Who's leading the race? A guide to coronavirus vaccines in the pipeline
This article from the ABC takes a closer look at some of the candidates in the race to making an effective SARS-CoV-2 vaccine. It looks at the ten vaccines currently in human trials (as at May 24, 2020).
Different kinds of vaccines in development are also discussed, both an experimental genetic vaccine as well as a viral vector vaccine; and which stage of trials these vaccines are currently at.
在这里阅读更多内容：
ABC: Who's leading the race? A guide to coronavirus vaccines in the pipeline
Stay tuned for our latest podcast series launching this week, COVID19 Road to a vaccine. Associate Professor Nigel Crawford, Director of SAEFVIC, will be discussing the different steps involved in creating a new vaccine with global vaccine experts.
Hepatitis A outbreak in Victoria
There is an ongoing hepatitis A outbreak in Victoria largely among people use drugs (primarily by injection) and people experiencing homelessness. According to the Department of Health, as of the 6th May 2020, there have been 56 confirmed cases and 6 possible cases associated with this outbreak since mid 2019.
In order to control this outbreak a hepatitis A vaccination program targeting affected people groups (people who use drugs and those experiencing homelessness) will be available until the 31st August, 2020.
Hepatitis B vaccine should also be offered as hepatitis B and C have a high rate of prevalence among people who inject drugs. Influenza vaccine should also be offered.
Read the full Department of Health advisory here: Hepatitis A outbreak
New NCIRS resource - Influenza vaccination during COVID-19 - FAQs for Aboriginal and Torres Strait Islander people
Aboriginal and Torres Strait Islander people are at an increased risk of serious disease when they contract influenza. During the current COVID-19 pandemic, it is more important than ever that Aboriginal Torres Strait Islander people are accessing an influenza vaccine. The influenza vaccine is funded under the National Immunisation Program for all Aboriginal and Torres Strait Islander people aged 6-months and over.
NCIRS have created a new FAQ resource addressing questions most frequently asked by people in the Aboriginal and Torres Strait Islander community:
NCIRS: Influenza vaccination during COVID-19 - FAQs for Aboriginal and Torres Strait Islander people
Are children with asthma at a greater risk of severe disease with COVID-19?
The Murdoch Children’s Research Institute (MCRI) are conducting extensive research into why children are more mildly affected by COVID-19. They are also investigating whether chronic health conditions such as asthma increase the risk of severe disease.
Read more about how children with asthma may be affected by COVID-19 at the link below:
MCRI: COVID-19 and asthma: what are the risks for children?
COVID-19 大流行期间维持免疫服务的 ATAGI 指导原则
Immunisation remains an essential service during the COVID-19 pandemic and it is very important immunisation providers maintain routine immunisation services whilst complying with measures to reduce the risk of transmission of COVID-19.
If scheduled vaccines are missed or delayed and the overall vaccination coverage rates drop, the risk of a resurgence of a well-controlled vaccine preventable disease like measles is increased. If this happens during or after the current pandemic, it places further stress on the health care system.
With this in mind, ATAGI (Australian Technical Advisory Group on Immunisation) have released guiding principles on maintaining immunisation services during the COVID-19 pandemic:
ATAGI: Guiding principles for maintaining immunisation services during the COVID-19 pandemic
流感疫苗和鸡蛋过敏
Based on prospective and retrospective studies of influenza vaccination in those with and without egg allergy (including egg anaphylaxis), the presence of egg allergy does not increase the risk of allergic reactions to the influenza vaccine and can be administered in a community immunisation setting, as a single dose, followed by the recommended 15 minute observation period.
For further information please see the following:
新的澳大利亚免疫手册应用程序
The Australian Immunisation Handbook is now available in an app! It can be downloaded from the App Store or Google Play.
Download Instructions:
- Search for "Immunisation Handbook" in either of the above app stores on the device you wish to add the Handbook App.
- Select the Australian Immunisation Handbook App. (Depending on your device, this may have either “Australian Department of Health” or “Medical” as the sub-header.)
- Click the Download icon to start.
- When the download is finished, you can open the App.
- The first time you open the App it will take approximately 1-2 minutes. (This is to store all the data into your device.)
世界免疫周 2020 年 4 月 24 日至 30 日
这是世界免疫周！
世界免疫周（WIW）的目的是促进疫苗的使用，以保护所有年龄段的人免受疾病侵害。每年，免疫接种可以挽救数百万人的生命，它被广泛认为是最成功和最具成本效益的健康干预措施之一。然而，全球仍有近 2000 万儿童未接种疫苗或疫苗接种不足。
作为疫苗安全网络（世界卫生组织建立的全球网站网络）的自豪成员，MVEC 很高兴庆祝 WIW。加入我们 Facebook
Instagram的 我们庆祝 WIW 的主题是 #VaccinesWork for All，重点关注开发、提供和接受疫苗的人们。在此阅读有关 WIW 的更多信息：
针对 COVID-19 的卡介苗疫苗临床试验 (BRACE)
在 Nigel Curtis 教授的领导下，默多克儿童研究所的研究人员正在进行一项针对 COVID-19 的 BCG 疫苗的随机对照临床试验。这项名为 BRACE 试验（卡介苗接种以减少澳大利亚医护人员接触冠状病毒后感染 COVID-19 的影响）的研究已得到世界卫生组织总干事谭德塞 (Tedros Adhanom Ghebreyesus) 的认可。
卡介苗 (BCG) 疫苗旨在提供预防结核病的保护，也可能提供免疫力以预防其他感染。 BRACE 试验的目的是调查 BCG 疫苗接种是否可以预防医护人员感染 COVID-19 或减轻其症状的严重程度。
这导致了人们 不要 符合寻求接种 BCG 疫苗的试验标准。
MVEC和医师BCG专家就这个问题达成了共识，具体如下：
| 我们强烈建议任何人不要在临床试验之外使用卡介苗，除非他们符合标准 澳大利亚免疫手册结核病指南. |
众所周知，卡介苗可以有效保护幼儿免受结核病的侵害，但近年来却受到全球短缺的影响。使用未经证实的疫苗（如卡介苗）会给接种者和处方者带来风险。此外，在试验之外额外使用卡介苗疫苗可能会导致需要该疫苗来预防结核病的婴儿短缺。由于目前海外旅行受到限制，许多提供卡介苗的旅行诊所已被暂停。然而，当旅行限制（包括前往结核病流行国家）取消时，旅行和医院卡介苗诊所将致力于增加疫苗的使用机会。
授权人：
- Nigel Curtis 博士、Nigel Crawford 博士、Jim Buttery 博士、Shidan Tosif 博士、Daryl Cheng 博士和 Teresa Lazzaro 博士
-2020 年 4 月 8 日
资源：
- MCRI：在冠状病毒暴露 (BRACE) 试验后，BCG 疫苗接种可减少澳大利亚医护人员感染 COVID-19 的影响
- MCRI：默多克儿童研究所将为 COVID-19 医护人员试验预防性疫苗
- MVEC：卡介苗 （包括维多利亚州的 BCG 诊所）
- 澳大利亚免疫接种手册：结核病
Telethon Kids 为家长、家庭和学校提供 COVID-19 资源
Telethon Kids Institute 为家长、家庭和学校创建了资源，其中专家提供最新建议并解决社区问题（包括社区孩子们的视频问答环节）。
他们的信息可靠、最新，并且基于现有的最佳证据。
您可以在以下位置查看他们的资源：